Infinium Pharmachem Ltd. (INFINIUM) Share Price Rise Streak: Second Straight Session Gains 18.95%

Infinium Pharmachem Ltd. Share Price is at Rs 317, up 8.77% today, with market capitalisation at Rs 415.29 crore. The move extends the second straight session and lifts the cumulative streak gain to 18.95%.

Infinium Pharmachem Ltd. Share Price Rise Streak now reflects a two-session pattern rather than a single-day move. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. The latest Univest figures show a company valued at Rs 415.29 crore, and the streak matters because consecutive higher closes can change how investors read price action versus one isolated gain. For readers tracking Infinium Pharmachem Ltd. Share Price, the key question is not only where the stock is trading now, but how the valuation, sector benchmark and peer set frame the move. Univest data helps place that change in context without turning it into a recommendation.

Infinium Pharmachem Ltd. Share Price Rise Streak: Consecutive Gain Analysis

Infinium Pharmachem Ltd. Share Price Rise Streak also gives a cleaner read than a one-off rise because the stock has now moved higher in the second straight session from a base of Rs 266.5 on 30 September 2026. That cumulative move matters for Infinium Pharmachem Ltd. Share Price analysis, but it still needs to be read alongside the company’s earnings base, book value and sector multiples. Univest places the streak in a factual frame: the pattern is visible, the valuation has moved with price, and the next useful check is whether the same readings still look stretched or aligned versus the chemicals universe.

Infinium Pharmachem Ltd. (INFINIUM) rose to Rs 317 from the previous close of Rs 291.45, a move of Rs 25.55 or 8.77%. The stock opened at Rs 290.55, reached a high of Rs 317, recorded a low of Rs 289.

Infinium Pharmachem Ltd. Share Price rose to Rs 317 after the stock had previously settled at Rs 291.45, marking a gain of Rs 25.55 or 8.77% in the latest session. This is the second straight session of higher closes, and the full streak now stands at 18.95% from Rs 266.5. The intraday path was straightforward: the stock opened at Rs 290.55, touched a low of Rs 289 and a high of Rs 317, and last traded at the day’s high. That places the latest Infinium Pharmachem Ltd. Share Price move firmly within the upper end of the session range. Market capitalisation stood at Rs 415.29 crore, which keeps the stock in a clearly defined listed-company size bracket while the price action itself remains the main short-term story. Infinium Pharmachem Ltd. Share Price analysis here is purely factual, with the next step being the fundamental read.

What the Consecutive Gains Show

The two-session pattern in Infinium Pharmachem Ltd. Share Price Rise Streak shows a cumulative 18.95% move from Rs 266.5, which is more informative than reading the latest session in isolation. The second straight session matters because the current price of Rs 317 is not just a higher print; it is a continuation of the same directional move. For Infinium Pharmachem Ltd. Share Price observers, the comparison between the first leg and the second leg is simple: the first session established the base, and the latest session added a larger rupee move of Rs 25.55. According to Univest data, the pattern is confirmed, but no company-specific catalyst is established. That is why Infinium Pharmachem Ltd. Share Price Rise Streak analysis should stay anchored to price behaviour first, then to valuation and sector context.

Infinium Pharmachem Ltd. (INFINIUM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 415.29 crore
P/E Ratio	37.38x
P/B Ratio	3.75x
ROE	12.32%
ROCE	13.55%
EPS	Rs 7.8
Book Value Per Share	Rs 77.68
Dividend Yield	0%

Infinium Pharmachem Ltd. (INFINIUM) fundamental metrics show P/E 37.38x, P/B 3.75x, ROE 12.32%, ROCE 13.55%. These figures provide context only and are not a buy or sell signal.

Infinium Pharmachem Ltd. has a market capitalisation of Rs 415.29 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.38x, P/B at 3.75x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.32% and ROCE of 13.55%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.8, book value per share of Rs 77.68, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.82x, median ROE of 7.76%, median ROCE of 10%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric	Value
Sector	Chemicals
Industry	Chemicals
Benchmark Scope	same industry
Company P/E Ratio	37.38x
Benchmark Median P/E	26.82x
Benchmark Average P/E	50.88x
Benchmark P/E Range	5.29x to 747.32x
Company P/B Ratio	3.75x
Benchmark Median P/B	2.06x
Company ROE	12.32%
Benchmark Median ROE	7.76%
Company ROCE	13.55%
Benchmark Median ROCE	10%
Company Market Capitalisation	Rs 415.29 crore
Benchmark Median Market Cap	Rs 492.51 crore

Infinium Pharmachem Ltd. (INFINIUM) operates in the Chemicals sector, within the Chemicals industry.

Infinium Pharmachem Ltd. (INFINIUM) has a P/E ratio of 37.38x, which is above the benchmark median of 26.82x, a difference of +39.37%. On its own, the P/E gap is a valuation reference point, not a trading call.

Infinium Pharmachem Ltd. (INFINIUM) has a ROE of 12.32%, which is above the benchmark median of 7.76%, a difference of +58.76%. Infinium Pharmachem Ltd. (INFINIUM) has a ROCE of 13.55%, which is above the benchmark median of 10%, a difference of +35.5%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Solar Industries India Ltd.	SOLARINDS	1,74,374.34	88.63	25.45	32.49	38.16
Pidilite Industries Ltd.	PIDILITIND	1,49,724.96	56.56	12.96	24.29	32.38
SRF Ltd.	SRF	72,170.55	33.92	4.97	13.8	14.21
Gujarat Fluorochemicals Ltd.	FLUOROCHEM	48,502.62	78.75	6.03	7.65	9.58
Navin Fluorine International Ltd.	NAVINFLUOR	42,246.33	53.59	10.08	20.24	21.39

Infinium Pharmachem Ltd. (INFINIUM) has a P/E ratio of 37.38x compared with the displayed peer median of 56.56x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 12.32% compares with a peer median of 20.24% across the companies shown in the table. ROCE stood at 13.55% versus the displayed peer median of 21.39%, providing a capital-efficiency comparison. Infinium Pharmachem Ltd. (INFINIUM) has a market capitalisation of Rs 415.29 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Infinium Pharmachem Ltd.

• Infinium Pharmachem Ltd. Share Price has now posted a second straight session of higher closes, which keeps the short-term pattern in focus.
• The latest Infinium Pharmachem Ltd. Share Price is Rs 317, with an 8.77% session move and a cumulative 18.95% streak gain.
• Infinium Pharmachem Ltd. Share Price now trades at 37.38 times earnings and 3.75 times book value, both above the same-industry median.
• ROE of 12.32% and ROCE of 13.55% give the Infinium Pharmachem Ltd. Share Price move a stronger profitability backdrop than the sector median.
• Infinium Pharmachem Ltd. Share Price also stands out because the chemicals peer set includes several larger names with very different valuation and return profiles.

About Infinium Pharmachem Ltd.

Infinium Pharmachem Ltd. operates in the chemicals sector and the chemicals industry, and that is the right lens for reading Infinium Pharmachem Ltd. Share Price today. The company’s listed profile is best understood through valuation, return ratios and market capitalisation rather than through a broad story of scale. At Rs 415.29 crore, the market cap keeps Infinium Pharmachem Ltd. Share Price in a smaller market-cap lane than several of the larger chemicals peers shown above. The business context matters because the current Infinium Pharmachem Ltd. Share Price Rise Streak is being assessed alongside sector benchmarks, not in isolation. For readers following Infinium Pharmachem Ltd. Share Price, the key business point is simple: this is a chemicals name whose market reading is now being shaped by a two-session price run, earnings multiple and book-value multiple more than by any visible external story.

Frequently Asked Questions

Why is Infinium Pharmachem Ltd. Share Price rising today?

Ans. Infinium Pharmachem Ltd. Share Price is higher for the second straight session, but according to latest Univest data, no company-specific catalyst is established. The move is best read as a confirmed price pattern rather than a stated event driver.

What is the current Infinium Pharmachem Ltd. Share Price?

Ans. Infinium Pharmachem Ltd. Share Price is Rs 317. The latest session added Rs 25.55, or 8.77%, and the cumulative two-session move now stands at 18.95% from the streak base of Rs 266.5.

What does the second straight session mean for Infinium Pharmachem Ltd. Share Price?

Ans. The second straight session means Infinium Pharmachem Ltd. Share Price has posted two consecutive higher closes. That pattern matters because it shows the latest move is part of a short streak, not a standalone intraday fluctuation.

How is Infinium Pharmachem Ltd. valued after the streak?

Ans. Infinium Pharmachem Ltd. Share Price now reflects a P/E of 37.38 and a P/B of 3.75. Since the earnings and book-value base has not changed across the streak, the higher multiple is driven by price.

How does Infinium Pharmachem Ltd. Share Price compare with the chemicals sector?

Ans. Infinium Pharmachem Ltd. Share Price trades above the same-industry median P/E of 26.82 and median P/B of 2.06. ROE at 12.32% and ROCE at 13.55% are also above the benchmark medians.

What is the market capitalisation of Infinium Pharmachem Ltd.?

Ans. Infinium Pharmachem Ltd. Share Price is backed by a market capitalisation of Rs 415.29 crore. That places the company below the sector median market capitalisation of Rs 492.51 crore in the same-industry benchmark.

What are the EPS and book value for Infinium Pharmachem Ltd. Share Price analysis?

Ans. EPS is Rs 7.8 and book value is Rs 77.68 per share. These figures help frame Infinium Pharmachem Ltd. Share Price because they show the earnings and accounting base behind the current valuation.

How does Infinium Pharmachem Ltd. compare with peers in chemicals?

Ans. Infinium Pharmachem Ltd. Share Price has a smaller market cap than the larger peer names shown, while its P/E is below some premium peers and above others. On ROE and ROCE, it sits in the middle of the set.

Track Infinium Pharmachem Ltd. Share Price on Univest

Use Infinium Pharmachem Ltd. (INFINIUM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Infinium Pharmachem Ltd. Share Price on Univest for live price updates, key valuation ratios, 52-week levels and market insights in one place. Univest also helps you follow Infinium Pharmachem Ltd. Share Price rise streaks, sector comparison and company fundamentals without turning the reading into a recommendation. If you are watching Infinium Pharmachem Ltd. Share Price today, the combination of price action and valuation context is the most useful starting point.